ID   TK [Human cholangiocarcinoma]
AC   CVCL_4Z42
SY   TanKan-gann
DR   Wikidata; Q54972515
RX   CelloPub=CLPUB00275;
RX   PubMed=10718366;
RX   PubMed=35640676;
CC   Population: Japanese.
CC   Doubling time: 29 hours (Note=At 13th passage) (PubMed=10718366).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C4436; Cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   78Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 29-06-23; Version: 8
//
RX   CelloPub=CLPUB00275;
RA   Zach S., Birgin E., Ruckert F.;
RT   "Primary cholangiocellular carcinoma cell lines.";
RL   J. Stem Cell Res. Transplant. 2:1013-1013(2015).
//
RX   PubMed=10718366; DOI=10.1290/1071-2690(2000)036<0104:HLOCCA>2.0.CO;2;
RA   Watanabe M., Chigusa M., Takahashi H., Nakamura J., Tanaka H.,
RA   Ohno T.;
RT   "High level of CA19-9, CA50, and CEA-producible human
RT   cholangiocarcinoma cell line changes in the secretion ratios in vitro
RT   or in vivo.";
RL   In Vitro Cell. Dev. Biol. Anim. 36:104-109(2000).
//
RX   PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007; PMCID=PMC9472155;
RA   Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y.,
RA   Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S.,
RA   Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.;
RT   "Development and characterization of human primary cholangiocarcinoma
RT   cell lines.";
RL   Am. J. Pathol. 192:1200-1217(2022).
//